Distalmotion's Dexter surgical robot gains CE mark

Distalmotion announced on Tuesday that it received the CE mark for its Dexter surgical robot, which the company said "combines the affordability of laparoscopy with the benefits of robotic surgery to bring simplicity and versatility in minimally invasive surgical care."

CEO Michael Friedrich remarked that obtaining the "CE mark is a major milestone paving the ground for the clinical use of Dexter in Europe." The executive noted that "Dexter has already garnered tremendous interest in the surgical community and we look forward to answering the increasing demand for a medical device removing the complexity out of robotic surgery to fast track its widespread adoption in minimally invasive surgical care."

The CE mark follows the validation of Dexter earlier this year when surgeons and nurses from European hospitals, across urology, gynaecology and general surgery confirmed the clinical benefits and value of the surgical robot.

To ensure you don't miss other Top Stories like these and news on key medtech industry developments, sign up for our free daily e-newsletter here.  

Did you like this article?